Auteur J. S. KRUGER

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Consumer experiences with delta-8-THC: Medical use, pharmaceutical substitution, and comparisons with delta-9-THC

D. J. KRUGER ; J. S. KRUGER | 2023
Dans Cannabis and Cannabinoid Research (Vol.8, n°1, February 2023) Article : Périodique

Introduction: Cannabis products containing delta-8-THC became widely available in most of the United States in late 2020 and rapidly became a significant source of revenue for hemp processing companies, especially in states where use of delta-9-[...]

Plus d'info

Ajouter à la sélection

Lien externe

Medical cannabis users' comparisons between medical cannabis and mainstream medicine

D. J. KRUGER ; J. S. KRUGER | 2019
Dans Journal of Psychoactive Drugs (Vol.51, n°1, January-March 2019) Article : Périodique

An evidence-based approach is needed to shape policies and practices regarding medical cannabis, thereby reducing harm and maximizing benefits to individuals and society. This project assesses attitudes towards and utilization of medical cannabi[...]

Plus d'info

Ajouter à la sélection

THC-O-acetate: Scarce evidence for a psychedelic cannabinoid

D. J. KRUGER ; C. C. BONE ; M. C. MEACHAM ; C. KLEIN ; J. S. KRUGER | 2024
Dans Journal of Psychoactive Drugs (Vol.56, n°4, September-October 2024) Article : Périodique

There is a growing interest in semi-synthetic cannabinoids, including THC-O-acetate (THC-Oac). Some cannabis marketers and users have claimed that THC-Oac produces psychedelic effects; the current study is the first to examine this claim. Resear[...]

Plus d'info

Ajouter à la sélection

Lien externe